Scalable growth today and tomorrow

Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.

Consolidate your assay menu

The Aptima® and Panther Fusion® assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

	Women's Health	Infectious Disease
	CT/NG	HIV-1 Quant Dx
	Mycoplasma genitalium	HCV Quant Dx
	Trichomonas vaginalis	HBV Quant
	Bacterial vaginosis	CMV†
	Candida vaginitis/Trichomonas vaginalis	Flu A/B/RSV
	HSV 1 & 2	Paraflu
	HPV	AdV/hMPV/RV
	HPV 16 18/45	SARS-CoV-2*
	Group B Strep	SARS-CoV-2/Flu/A/B*
	Zika Virus*	SARS-CoV-2/Flu/A/B/RSV†
		GI Panel†

What will you build?

		Panther® System The foundation for assay consolidation, future scalability and growth Add the Panther system to your lab and the capability to consolidate menu on a fully automated system, load samples in any order at any time, eliminate batch constraints and decrease turnaround time. View Details
		Panther Fusion® System Flexibility, capacity and expanded menu, plus the ability to run laboratory developed tests Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. The Panther Fusion® module enables you to consolidate testing, increase walkaway time and enhance flexibility. View Details
		Panther® Plus Increased capacity, walkaway time and throughput in 24 hours Add on capacity with the MTU expansion module and gain the ability to plumb liquid waste and continuously dispose of fluids/wastes. View Details
		Panther® Link Virtually connected Panther systems share information and monitor from a centralized dashboard Add on freedom by virtually connecting multiple Panther instruments, giving you the ability to share inventories, reagents and results while monitoring your entire fleet from a core location. View Details
		Panther® Trax†‡  Physically connected Panther systems grow testing volumes without increasing staff Add on a track system that enables sample to storage automation, giving your molecular lab the potential to grow as you grow. View Details

* The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

† In Development and not for sale

‡  Upgrades will not be available for Panther Fusion at launch.